✦ LIBER ✦

c-erbB-2 and the “triple-state” in early breast carcinomas

✍ Scribed by Efthimios Sivridis; Charilaos Stamos; Aliki Fiska; Nikolaos Nikolettos; Michael I. Koukourakis; Alexandra Giatromanolaki

Book ID: 107576879
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 245 KB
Volume: 27
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-009-9252-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

c-erbB-2 and the “triple-state” in early

c-erbB-2 and the “triple-state” in early breast carcinomas

✍ Efthimios Sivridis; Charilaos Stamos; Aliki Fiska; Nikolaos Nikolettos; Michael 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 245 KB

C-erbB-2 overexpression and survival in

C-erbB-2 overexpression and survival in early onset breast cancer

✍ Måns Agrup; Olle Stäl; Karen Olsen; Sten Wingren 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 59 KB

Estrogen receptor-α and C-ERBB-4 express

Estrogen receptor-α and C-ERBB-4 expression in breast carcinomas

✍ Zhenhe Suo; Heidi Siri Berner; Björn Risberg; Mats G. Karlsson; Jahn M. Nesland 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 210 KB

Serial serum c-erbB-2 levels in patients

Serial serum c-erbB-2 levels in patients with breast carcinoma

✍ Gena H. Volas; Kim Leitzel; Yoshio Teramoto; Howard Grossberg; Laurence Demers; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

## Background: Recently, the extracellular domain of the c-erbb-2 oncogene product (her-2/neu) has been reported to be elevated in the serum of one-fourth of patients with metastatic breast carcinoma. the role of serum c-erbb-2 as a tumor marker, however, is still poorly defined. the purpose of thi

c-erbB-2 over-expression in amplified an

c-erbB-2 over-expression in amplified and non-amplified breast carcinoma samples

✍ Fulvia Farabegoli; Claudio Ceccarelli; Donatella Santini; Nicola Baldini; Mario 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 124 KB 👁 1 views

We investigated c-erbB-2 oncogene amplification and overexpression in 79 invasive breast carcinoma samples using fluorescence in situ hybridization (FISH) and immunohistochemistry, with the aim of studying relationships between neoplasms over-expressing c-erbB-2 with or without amplification and bio

C-erbB-2 oncoprotein in screen-detected

C-erbB-2 oncoprotein in screen-detected breast carcinoma: An immunohistological study

✍ Salma Soomro; P. Taylor; H. M. Shepard; M. Feldmann; H. D. Sinnett; S. Shousha 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 344 KB

This study was aimed at comparing screen-detected and symptomatic breast carcinomas with regard to the prevalence of positive immunostaining for c-erb-B-2 oncoprotein. Paraffin sections of 8 I breast carcinomas detected through the National Screening Programme were examined for the over-expression o